Common Stock, Shares, Outstanding of Neurogene Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Neurogene Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Neurogene Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 14,775,285, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Neurogene Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 14,775,285 +1,764,418 +14% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 14,269,264 +1,280,056 +9.9% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 14,929,566 +2,068,571 +16% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 14,854,725 +2,031,060 +16% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 13,010,867 +4,205,583 +48% 30 Sep 2024 10-Q 18 Nov 2024 2024 Q3
Q2 2024 12,989,208 -31,032,221 -70% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 12,860,995 -29,957,351 -70% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 12,823,665 +12,823,665 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 8,805,284 -33,789,318 -79% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 44,021,429 +1,441,577 +3.4% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 42,818,346 +324,375 +0.76% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 0 -42,457,471 -100% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 42,594,602 +166,468 +0.39% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 42,579,852 +160,723 +0.38% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 42,493,971 +167,938 +0.4% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 42,457,471 +261,175 +0.62% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 42,428,134 +551,544 +1.3% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 42,419,129 +3,932,587 +10% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 42,326,033 +3,939,873 +10% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 42,196,296 +4,199,447 +11% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 41,876,590 +13,736,347 +49% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 38,486,542 +14,949,174 +64% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 38,386,160 +14,848,792 +63% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 37,996,849 +14,459,481 +61% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 28,140,243 +4,602,875 +20% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 23,537,368 0 0% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 23,537,368 +45,207 +0.19% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 23,537,368 +64,938 +0.28% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 23,537,368 +72,438 +0.31% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 23,537,368 +72,656 +0.31% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 23,492,161 +69,011 +0.3% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 23,472,430 +49,280 +0.21% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 23,464,930 +41,780 +0.18% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 23,464,712 +6,252,075 +36% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 23,423,150 +6,211,164 +36% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 23,423,150 +6,211,164 +36% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 23,423,150 +6,211,164 +36% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 17,212,637 +6,485,416 +60% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 17,211,986 +6,488,858 +61% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 17,211,986 +6,516,878 +61% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q3 2015 17,211,986 30 Sep 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 10,727,221 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 10,723,128 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 10,695,108 +10,393,363 +3444% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 301,745 31 Dec 2013 10-K 16 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.